Protivoopukholevye vaktsiny na osnove dendritom

K D Nikitin , M A Rubtsova , I A Utyashev , A Yu Baryshnikov

Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (2) : 48 -53.

PDF
Russian Journal of Oncology ›› 2010, Vol. 15 ›› Issue (2) : 48 -53. DOI: 10.17816/onco39745
Articles
other

Protivoopukholevye vaktsiny na osnove dendritom

Author information +
History +
PDF

Abstract

Immunotherapy is an oncology area that studies how to treat malignancies, by activating and/or potentiating an antitumor immune response in the patient. Much attention is given to the use of dendritic cells and their based agents (vaccines). Pilot clinical trials have demonstrated that dendritic cells loaded with tumor antigens induce an immune response that is specific to tumor-associated antigens. Dendritic/tumor cell fusion is one of the most original and very promising methods for enhancing the efficacy of dendritic cell vaccines. The present overview presents information on the dendritoma obtaining procedure, discusses the specific features of the biology of hybrid cells, and the results of their experimental study. Particular emphasis is laid on the data of clinical studies of dendritomas in patients with malignancies.

Keywords

antitumor vaccines / dendritomes

Cite this article

Download citation ▾
K D Nikitin, M A Rubtsova, I A Utyashev, A Yu Baryshnikov. Protivoopukholevye vaktsiny na osnove dendritom. Russian Journal of Oncology, 2010, 15(2): 48-53 DOI:10.17816/onco39745

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Akasaki Y., Kikuchi T., Homma S. et al. // J. Immunother. - 2001. - Vol. 24. - P. 106-113.

[2]

Avigan D., Vasir B., Gong J. et al. // Clin. Cancer Res. - 2004. - Vol. 10. - P. 4699-4708.

[3]

Avigan D. E., Vasir B., George D. J. et al. // J. Immunother. - 2007. - Vol. 30, N 7. - P. 749-761.

[4]

Celluzzi C. M., Mayordomo J. I., Storkus W. J. et al. // J. Exp. Med. - 1996. - Vol. 183. - P. 283-287.

[5]

Du Y. C., Lin P., Zhang J. et al. // Tissue Antigens. - 2006. - Vol. 67. - P. 368-376.

[6]

Fabre J. W. // Nat. Med. - 2001. - Vol. 7. - P. 649-652.

[7]

Gogas H., Ioannovich J., Dafni U. et al. // N. Engl. J. Med. - 2006. - Vol. 354. - P. 709-718.

[8]

Gong J., Chen D., Kashiwaba M. et al. // Nat. Med. - 1997. - Vol. 3. - P. 558-561.

[9]

Gong J., Chen L., Chen D. et al. // Gene Ther. - 1997. - Vol. 4. - P. 1023-1028.

[10]

Gong J., Chen D., Kashiwaba M. et al. // Proc. Natl. Acad. Sci. USA. - 1998. - Vol. 95. - P. 6279-6283.

[11]

Gong J., Nikrui N., Chen D. et al. // J. Immunol. - 2000. - Vol. 165. - P. 1705-1711.

[12]

Gong J., Koido S., Chen D. et al. // Blood. - 2002. - Vol. 99. - P. 2512-2517.

[13]

Guo G., Chen S., Zhang J. et al. // Vaccine. - 2005. - Vol. 23. - P. 5225-5230.

[14]

Guo G. H., Chen S. Z., Yu J. et al. // Wld J. Gastroenterol. - 2008. - Vol. 14, N 8. - P. 1167-1174.

[15]

Haenssle H. A., Krause S. W., Emmert S. et al. // J. Immunother. - 2004. - Vol. 27, N 2. - P. 147-155.

[16]

Homma S., Sagawa Y., Ito M. et al. // Clin. Exp. Immunol. - 2006. - Vol. 144. - P. 41-47.

[17]

Hsu F. J., Benike C., Fagnoni F. et al. // Nat. Med. - 1996. - Vol. 2. - P. 52-58.

[18]

Iinuma T., Homma S., Noda T. et al. // J. Clin. Invest. - 2004. - Vol. 113. - P. 1307-1317.

[19]

Irie M., Homma S., Komita H. et al. // Int. J. Cancer. - 2004. - Vol. 111. - P. 238-245.

[20]

Kikuchi T., Akasaki Y., Irie M. et al. // Cancer Immunol. Immunother. - 2001. - Vol. 50, N 7. - P. 337-344.

[21]

Koido S., Kashiwaba M., Chen D. et al. // J. Immunol. - 2000. - Vol. 165. - P. 5713-5719.

[22]

Koido S., Tanaka Y., Chen D. et al. // J. Immunol. - 2002. - Vol. 168. - P. 2111-2117.

[23]

Koido S., Ohana M., Liu C. et al. // Clin. Immunol. - 2004. - Vol. 113. - P. 261-269.

[24]

Koido S., Hara E., Homma S. et al. // Clin. Cancer Res. - 2005. - Vol. 11. - P. 7891-7900.

[25]

Koido S., Hara E., Torii A. et al. // Int. J. Cancer. - 2005. - Vol. 117. - P. 587-595.

[26]

Koido S., Hara E., Homma S. et al. // J. Immunol. - 2007. - Vol. 178. - P. 613-622.

[27]

Koido S., Tanaka Y. Tajiri H. et al. // Vaccine. - 2007. - Vol. 25. - P. 2610-2619.

[28]

Kufe D. W. // Nat. Med. - 2000. - Vol. 6. - P. 252-253.

[29]

Mackensen A., Herbst B., Chen J. L. et al. // Int. J. Cancer. - 2000. - Vol. 86. - P. 385-392.

[30]

Märten A., Renoth S., Heinicke T. et al. //Hum. Gene Ther. - 2003. - Vol. 14. - P. 483-494.

[31]

Matsuda K., Tsunoda T., Tanaka H. et al. // Cancer Immunol. Immunother. - 2004. - Vol. 53. - P. 609-616.

[32]

Mayordomo J. I., Zorina T., Storkus W. J. et al. // Nat. Med. - 1995. - Vol. 1. - P. 1297-1302.

[33]

Nestle F. O., Alijagic S., Gilliet M. et al. // Nat. Med. - 1998. - Vol. 4. - P. 328-332.

[34]

Paglia P., Chiodoni C., Rodolfo M. et al. // J. Exp. Med. - 1996. - Vol. 183. - P. 317-322.

[35]

Phan V., Errington F., Cheong S. C. et al. // Nat. Med. - 2003. - Vol. 9. - P. 1215-1219.

[36]

Rowse G. J., Tempero R. M., VanLith M. L. et al. // Cancer Res. - 1998. - Vol. 58. - P. 315-321.

[37]

Russo V., Tanzarella S., Dalerba P. et al. // Proc. Natl. Acad. Sci. USA. - 2000. - Vol. 97. - P. 2185-2189.

[38]

Savai R., Schermuly R. T., Schneider M. et al. // J. Immunother. - 2006. - Vol. 29. - P. 175-187.

[39]

Tanaka Y., Koido S., Chen D. et al. // Clin. Immunol. - 2001. - Vol. 101. - P. 192-200.

[40]

Tanaka Y., Koido S., Ohana M. et al. // J. Immunol. - 2005. - Vol. 174. - P. 1274-1280.

[41]

Thurner B., Haendle I., Roder C. et al. // J. Exp. Med. - 1999. - Vol. 190. - P. 1669-1678.

[42]

Trefzer U., Herberth G., Wohlan K. et al. // Vaccine. - 2005. - Vol. 23. - P. 2367-2373.

[43]

Wang J., Saffold S., Cao X. T. et al. // J. Immunol. - 1998. - Vol. 161. - P. 5516-5524.

[44]

Wei Y., Sticca R. P., Holmes L. M. et al. // Int. J. Oncol. - 2006. - Vol. 28. - P. 585-593.

[45]

Wei Y. C., Sticca R. P., Li J. et al. // Oncol. Rep. - 2007. - Vol. 18, N 3. - P. 665-671.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

120

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/